News & Analysis on Clinical Trial Services & Contract Research And Development
US target discovery company Psychiatric Genomics has shed new light on the mechanisms behind schizophrenia, pointing to a possible new cellular target that does not rely on modulating the levels of neurotransmitters in the brain.
QTL Biosystems announced the introduction of its QTL LightSpeed Kinase platform and four new kinase Activity Assays, which uses a unique polymer technology that does not require antibodies or radioactive labels, providing a distinct advantage over...
Swiss biopharmaceuticals company BioPartners has filed its first application in Europe for a generic version of interferon alpha, a biological drug. If approved, the 'biosimilar' could be on the market as early as next year.
US life science company Serologicals' decision to enter into a €167.6 million merger with cell signalling specialist Upstate looks to have been the right one as its third quarter performance indicates its increasing presence in the preclinical drug...
BioProgress, a developer of film strips and cellulose-based capsules for drug and vitamin delivery, is increasing its international presence, signing its first agreement for a line of products for the Chinese market.
Novis, now with almost half a million readers, last week earned broad industry recognition with two further publishing awards, following on from its best publication prize earlier this year.
Regen Therapeutics (ReGen) announced it had entered into an agreement to acquire Guildford Clinical Pharmacology Unit Limited (GCPUL) confirming its strategy to develop its medical service revenue generating business and developing its Alzheimers...
The growing loss of patent protection on blockbuster drugs over the next few years and the rising need to contain spiralling healthcare costs are going to lend significant impetus to the growth of Europe's generics and biogenerics market, says a new...
India is gearing up for the introduction of new legislation on intellectual property that will bring it into line with its World Trade Organisation commitments.